New discovery may block ALS disease process
April 19, 2011 in GeneticsNew Orleans, LA In the first animal model of Amyotrophic Lateral Sclerosis (ALS), developed by Dr. Udai Pandey, Assistant Professor of Genetics at LSU Health Sciences Center New Orleans, Dr. Pandey's lab has found in fruit flies that blocking the abnormal movement of a protein made by a mutated gene called FUS also blocks the disease process. The research is available online in the Advanced Access section of the journal Human Molecular Genetics website, posted on April 12, 2011. It will be published in an upcoming issue of the journal.
The fruit flies were engineered to carry and express a mutated human FUS gene. This mutated FUS gene has been shown to be one of the major causes of both familial and sporadic ALS. In the fruit flies, the resulting neurodegeneration impairs their ability to walk or climb and the defect is also easily visualized in the structure of their eyes. In addition, the flies carrying the defective FUS gene demonstrate hallmarks of the human disease, such as an age-dependent degeneration of neurons, accumulation of abnormal proteins and a decrease in life span.
Also as seen in human ALS patients, the disease-causing FUS protein that's formed from the gene abnormally moves to the cytoplasm rather than staying in the cell nucleus. Dr. Pandey's lab found that blocking this abnormal migration could block the disease process. All these features make the fly model a valuable resource for performing drug screens to identify drugs that could modify the effects of the mutated gene.
"These findings prompt us to look for drugs that can help in keeping the defective FUS protein in the nucleus as a potential therapeutic intervention" notes Pandey. "The fly model is an inexpensive and fast way to study many human diseases such as cancer, Alzheimer's disease and Parkinson's disease. Many basic biological processes are well conserved between humans and fruit flies, and nearly 75% of human disease-causing genes are believed to have a functional partner (homolog) in the fly that makes these small animals a highly tractable model system."
Dr. Pandey's group found that normal FUS interacts with another major human ALS-linked protein TDP-43, but mutated FUS interacts abnormally with normal TDP-43. Mutations in the TDP-43 gene have also been found to cause ALS. Interestingly, these two ALS-linked proteins do not seem to interact if trapped in the nucleus.
According to the National Institutes of Health, Amyotrophic Lateral Sclerosis, sometimes called Lou Gehrig's disease, is a rapidly progressive, invariably fatal neurological disease that attacks the nerve cells (neurons) responsible for controlling voluntary muscles. The disease belongs to a group of disorders known as motor neuron diseases, which are characterized by the gradual degeneration and death of motor neurons. Motor neurons are nerve cells located in the brain, brainstem, and spinal cord that serve as controlling units and vital communication links between the nervous system and the voluntary muscles of the body. Messages from motor neurons in the brain (called upper motor neurons) are transmitted to motor neurons in the spinal cord (called lower motor neurons) and from them to particular muscles. In ALS, both the upper motor neurons and the lower motor neurons degenerate or die, ceasing to send messages to muscles. Unable to function, the muscles gradually weaken, waste away (atrophy), and twitch (fasciculations). Eventually, the ability of the brain to start and control voluntary movement is lost.
"Our next goal is to identify other factors such as proteins or RNA that mutant forms of FUS target so that we can get more insights into the disease mechanisms" said Nicholas Lanson Jr., an LSUHSC research associate and first author of the paper.
Provided by Louisiana State University Health Sciences Center
-
Researchers discover genetic link between both types of ALS
May 05, 2010 |
not rated yet |
0
-
Lou Gehrig's protein found throughout brain, suggesting effects beyond motor neurons
Jun 16, 2008 |
not rated yet |
0
-
Malfunctioning gene associated with Lou Gehrig's disease leads to nerve-cell death in mice
Jan 04, 2011 |
not rated yet |
0
-
Researchers identify a gene responsible for Lou Gehrig's disease
Mar 31, 2008 |
not rated yet |
0
-
Second MND gene mutation in one year signifies rapid research progress
Feb 26, 2009 |
not rated yet |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (42) |
45
-
Your brain on dye: Imaging neuronal voltage with fluorescent sensors and molecular wires
Feb 24, 2012 |
4.9 / 5 (9) |
0
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Distinct molecular subtype of prostate cancer identified
A collaborative expedition into the deep genetics of prostate cancer has uncovered a distinct subtype of the disease, one that appears to account for up to 15 percent of all cases, say researchers at Weill Cornell Medical ...
Genetics
18 hours ago |
5 / 5 (1) |
0
|
Gene mapping reveals architecture that controls expression of genes responsible for our sense of smell
Within the nasal cavity, millions of sensory neurons in a postage-stamp-sized patch of tissue called the olfactory epithelium control our sense of smell. Thanks to the exquisitely controlled expression of ...
Genetics
May 18, 2012 |
5 / 5 (1) |
1
'Rare' genetic variants are surprisingly common, life scientists report
(Medical Xpress) -- A large survey of human genetic variation, published today in the online version of the journal Science, shows that rare genetic variants are not so rare after all and offers insights into h ...
Genetics
May 18, 2012 |
5 / 5 (4) |
0
|
Abundance of rare DNA changes following population explosion may hold clues to common diseases
One-letter switches in the DNA code occur much more frequently in human genomes than anticipated, but are often only found in one or a few individuals.
Genetics
May 17, 2012 |
not rated yet |
0
|
Genetic testing may not trigger more use of health services
People have more and more chances to participate in genetic testing that can indicate their range of risk for developing a disease. Receiving these results does not appreciably drive up or diminishtest recipients' ...
Genetics
May 17, 2012 |
not rated yet |
0
Research holds out hope for stroke patients
(Medical Xpress) -- People with a curious condition that causes them to apply make-up on only one side of their face, or ignore food on half of their plate, are playing a new role in understanding stroke recovery.
Building a drug delivery platform to regenerate heart tissue
(Medical Xpress) -- While current heart-attack treatments mainly try to preserve healthy heart tissue, scientists have been finding compounds that can stimulate growth of new tissue – either by getting heart muscle ...
Woman with flesh-eating disease takes own breaths
(AP) -- The father of a young Georgia woman fighting a flesh-eating bacteria says his daughter is now breathing on her own.
Inadequate pain meds in ER for patients with long-bone fractures
(HealthDay) -- The majority of patients with long-bone fractures receive inadequate pain medication in the emergency department, and disparities in management exist, according to a study published in the May ...
Folic acid may reduce some childhood cancers
Folic acid fortification of foods may reduce the incidence of the most common type of kidney cancer and a type of brain tumors in children, finds a new study by Kimberly J. Johnson, PhD, assistant professor at the Brown School ...
Blocking DNA: HDAC inhibitor targets triple negative breast cancer
The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research. Researchers from T ...